MJN +4% on China’s 1-child policy change. As a company almost solely devoted to infant and pre-natal nutrition, MJN may be the “purest” publicly-traded multinational on this theme.
Among stocks I hold, ABT (which derives 10-15% of sales from infant and pre-natal nutrition) was +1% today.